Does twice-weekly administration of peginterferon alfa-2b really improve viral kinetics in patients with chronic hepatitis C genotype 1? (multiple letters)

Journal of Viral Hepatitis

Volumn 11, Issue 2, 2004, Pages 187-188

  Buti, M ^a   Esteban, R ^a   Jacobson, I M ^b,c   McHutchison, J ^b   Ferenci, Peter ^b,d  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PEGINTERFERON ALPHA2B;

ANTIVIRAL ACTIVITY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HEPATITIS C; HUMAN; LETTER; PRIORITY JOURNAL; RNA ANALYSIS; SEX RATIO; STATISTICAL SIGNIFICANCE;

EID: 1642402777     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2003.00493.x     Document Type: Letter

References (0)